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Hematopoietic stem cells expand during serial transplantation in
vivo without apparent exhaustion
Norman N. Iscove and Katsuhiko Nawa*
Whether hematopoietic stem cells can proliferate
without limit, or whether their regenerative capacity
declines with repeated division, has been debated for
decades. Prevailing opinion favours an intrinsic
‘decline’, a view based on the finite degree to which
murine bone marrow can be serially transplanted [1,2],
the diminished self-renewal of spleen colony-forming
cells (CFU-s) subjected to repeated passage [1], and the
failure of stem cells to regenerate to normal levels after
even a single transplantation [3,4]. However, serial
transfer experiments did not specifically monitor input
and output of long-lived stem cells (long-term
reconstituting cells, LTRCs), leaving competing
interpretations unresolved. We have re-examined the
issue by quantitating 7–12 month LTRCs during
sequential transplantations. Although these cells
recovered to only 4% of normal levels after primary
bone marrow transplantation, at each passage they
increased around 10-fold relative to the amount
transplanted, attaining an estimated cumulative
expansion of 8400-fold over the original input after four
transfers. Expansion was limited by transfer of
increasing numbers of marrow cells and specifically of
LRTCs, suggesting an extrinsically determined ceiling to
stem cell growth. Conversely, expansion was enhanced
in vivo by administration of stem cell factor (SCF, c-kit
ligand) and interleukin-11. The results challenge the
view that expansion of passaged stem cells is limited
by exhaustion, and indicate that augmentation after
transplant is limited by extrinsic mechanisms whose
effects are reversible either by further transfer of the
stem cells into irradiated hosts or by administration of
exogenous cytokines. 
Address: The Ontario Cancer Institute and Department of Medical
Biophysics, University of Toronto, 610 University Avenue, Toronto
M5G 2M9, Canada.
Present Address: *Daiichi Pharmaceutical Co. Ltd., Kitakasai 1-16-13,
Edogawa, Tokyo 134, Japan
Correspondence: Norman N. Iscove
E-mail: iscove@oci.utoronto.ca
Received: 19 May 1997
Revised: 28 July 1997
Accepted: 7 August 1997
Current Biology 1997, 7:805–808
http://biomednet.com/elecref/0960982200700805
© Current Biology Ltd ISSN 0960-9822
Results and discussion
A single stem cell is sufficient to reconstitute durably the
entire hematopoietic and lymphoid tissues of a murine
recipient for periods of a year or more [5–7]. The ability of
marrow from such recipients to reconstitute secondary
recipients with cells deriving from the original reconstitut-
ing cell established the principle of stem cell ‘self
renewal’ [6,8,9]. Limits to regeneration in serial transplan-
tation experiments, however, led to the widely held view
that stem cells may be intrinsically limited in their poten-
tial for self-renewal in a manner analogous to the
‘Hayflick’ ceiling identified for proliferation of untrans-
formed fibroblasts [10]. 
Early attempts to quantitate stem cell renewal relied on
measurements of CFU-Ss detected by their ability to prolif-
erate for 8–12 days. When normal marrow was transplanted
into irradiated mice, the number of CFU-Ss in marrow
recovered rapidly to normal levels [11], but displayed a
diminished capacity for self-renewal described as ‘decline’
[1]. Subsequently, LTRCs were found to regrow to only
3–4% of normal levels even after months of recovery [3,4],
reinforcing the view that self-renewal of stem cells might be
fundamentally limited. The extent of stem-cell renewabil-
ity is of particular interest in view of current efforts to
obtain expansion of human stem cells in culture preparatory
to transplantation, despite the scarcity of evidence that sig-
nificant expansion is feasible or whether it can happen
without incurring a penalty in transplant durability. 
Our experiments were designed to track murine LTRCs
quantitatively during successive transplantations into
lethally irradiated hosts. A competitive 30–52 week ery-
throid reconstitution assay was used [3,4] in which donor
cells differed from congenic host and competitor cells by a
quantifiable electrophoretic mobility marker, GPI1. The
assay readout is related linearly to the number of injected
test stem cells [12] and defines a competitive unit (CU) as
the long-term reconstituting (LTR) activity present in
2 × 106 normal marrow cells. On the basis of limiting dilu-
tion analyses [12,13], 1 CU would correspond to approxi-
mately 200 LTRCs. A normal mouse has on average
2.75 × 108 marrow cells containing 138 CU.
Table 1, series I, shows that lethally irradiated mice
injected with 1 × 106 normal marrow cells (0.5 CU) regener-
ated to a whole-mouse total of 5.18 CU of donor type in
their marrow, a level that is only 4% of normal, 29–66 weeks
post-transplant. However, this level also represented a
10.4–fold increase over the number of CU originally
injected, establishing the capacity of LTRC to increase in
the milieu of the irradiated host. Other experiments deter-
mined that this level of regeneration was reached by 6
weeks and changed little thereafter. The failure of stem
cells to rise to normal levels did not reflect their quiescence,
since at least 80% of LTRC in marrow were reproducibly
eliminated in mice 6 months post-transplant within
48 hours of a single administration of the cytotoxic agent 5-
fluorouracil (not shown).
Further transfers were then performed to assess the capac-
ity of stem cells to regenerate as a function of proliferative
history. Anticipating that the amount of LTR activity in
recipient marrow would be substantially reduced, increased
numbers of cells were passaged forward so that similar
amounts of LTR activity would be transferred at each
passage. The expectation was that if the ability of LTRCs
to self-renew diminished with passaging, we should observe
diminishing fold-increases in each succeeding transfer.
Table 1, series I, shows results pooled from three indepen-
dent experiments, each involving 2–4 serial transplanta-
tions, the longest series spanning 4 years. LTRCs increased
5–13-fold at each of up to three successive transfers,
without evidence of diminishing regenerative capacity. A
further 13-fold expansion was measured, with less preci-
sion, at a fourth transfer, yielding a cumulative expansion of
8400-fold over the LTR activity initiating the experiment.
A second series was undertaken to determine whether
serial passage of increased numbers of cells would demon-
strate similar increases at higher reconstitution levels.
Contrary to expectations, this strategy did not significantly
enhance reconstitution. Moreover, as shown in Table 1,
Series II, fold-increases of LTR activity were distinctly
lower than those obtained in series I. As in the first series,
however, there was no evidence of diminished regenera-
tive ability with serial passage; indeed, fold-expansion
actually increased in successive transfers.
Together, these results suggested that the fold-increase of
LTRC in irradiated hosts may correlate negatively with
the number of passaged cells. We therefore tested LTRC
regeneration after injection of from 1 × 106 to
30 × 106 cells (Supplementary material). The results con-
firmed that high fold-expansion of LTR activity occurred
only with transfer of fewer than 3 × 106 normal marrow
cells or fewer than 1.5 CU. Regardless of the number of
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Table 1
Stem cell expansion during serial transfer in irradiated hosts.
Passage Regenerated/mouse Passaged forward
Weeks Cells (108) CU Cells (106) CU Out/in
Series I
Original ‘2.75’ ‘138’ 1 ‘0.5’
1° (3) 29–66 3.20 5.18 10–20* 0.224* 10.4 ± 3.5
2° (3) 28–36 3.85 2.91 20 0.476 13.0 ± 5.7
3° (2) 35–39 2.71 2.31† 20 0.0285† 4.8 ± 2.0
4° (1) 39 2.36 0.370‡ 13.0 ± 5.5
Cumulative fold-increase: 8440
Series II 
Original ‘2.75’ ‘138’ 30 ‘15’
1° (2) 9–12 4.11 13.6 48.7 1.62 0.91 ± .38
2° (2) 9–11 3.71 3.63 34.8 0.343 2.24 ± .94
3° (2) 10–12 3.16 2.09 6.09 ± 2.6
Cumulative fold-increase: 12.4
Diagrammatic representations of the experimental protocols are
published as Supplementary material with this paper on the internet.
C57BL/6J-GPI1b mice were γ-irradiated (900r,137Cs) before injection
of marrow cells from congenic C57BL/6J-GPI1a mice or from
previously transplanted recipients. Values in quotation marks represent
historical averages for marrow from normal mice. Numbers of
independent passage series contributing to each mean are indicated in
parentheses. Typically, marrow to be quantitated was pooled from two
or three reconstituted mice and 10–50 × 106 (series I) or 4–17 × 106
(series II) cells infused into three γ-irradiated recipients together with
2 × 106 GPI1b competitor marrow cells. After a minimum of 32 weeks,
the ratio of blood erythrocyte GPI1a to GPI1b was determined in each
recipient, yielding the number of CUs contained in the tested marrow
aliquot. Mean percentages of GPI1a in competitive assay recipients of
1°–3° marrows in series I were 39.6, 15.7, and 26.0, and in series II
10.0, 1.6 and 5, respectively. Values below 5% were adjusted
according to gel readouts from calibration mixtures of GPI1a and
GPI1b red cells. For calculation of total marrow CU, each sampled
tibia and femur was considered to represent 2.5% and 5% of the total
donor marrow cells respectively. S.e.m. values for the computed in/out
ratios were obtained by direct measure of ratio variance series-to-
series, or estimated from historical coefficients of variation where only
a single ratio was determined. Cumulative fold-increase is the product
of the individual increases at each passage. *From primary marrow
recipients, 10–20 × 106 cells containing an average of 0.224 CU were
transferred into irradiated 2° recipients. †In two experiments, 3°
recipient mice regenerated to an average of 2.31 CU. Tertiary marrow
from one of the experiments, which had regenerated to 0.34 CU, was
further passaged (0.0285 CU) into 4° recipients. ‡GPI1a readings
were just above detectability. The calibration correction was 10-fold.
marrow cells injected, mice regenerated to a whole-
marrow total of only 3–14 CUs. This result suggests the
existence of a ceiling for the eventual level of LTRC
reconstitution, and further suggests that the extent of
expansion of LTRC numbers is not autonomously set.
Similar observations based on limiting dilution measure-
ments were recently reported by Pawliuk et al. [14].
Transfer of increased numbers of cells also entails trans-
fer of increased numbers of stem cells. Our results sug-
gested that expansion may be more closely related to the
amount of transplanted LTR activity than to cell
numbers. For example, passage of 30 × 106 fresh marrow
cells yielded no net expansion, while transfer of 35 × 106
cells from secondary recipients yielded sixfold increase of
LTRCs in tertiary recipients (Table 1, series II). Figure 1
plots all our data points as fold-expansion against either
number of cells transferred or amount of transplanted
LTR activity. While a weak negative correlation is
evident with the number of cells, it is much stronger  with
transferred LTR activity. The relationship was further
tested by cell separation, as in [15], to enrich LTRCs
100–250-fold relative to other cells measurable in colony
assays. Mixing experiments confirmed that fold-expan-
sion was correlated with amount of injected LTRCs and
not with total injected cell numbers or numbers of
colony-forming cells (not shown).
Marrow cellularity is generally restored within 2 weeks of
transplant [1,11], and recovery is faster when more recon-
stituting cells are transferred. We considered that stem
cell increase might be driven by endogenous cytokines
upregulated after irradiation. Premature cessation of stem
cell regeneration could result if these cytokines were
downregulated via feedback mechanisms determined by
marrow bulk rather than the number of stem cells. Since
these stem cells can increase again in freshly irradiated
hosts, they might also respond in situ to exogenously
administered cytokines.
Resting LTRCs from normal marrow respond to SCF and
IL-11 in vitro by entry into the cell cycle and generation of
progeny that retain long term reconstituting capacity [15],
and by increase in vivo [16,17]. We accordingly adminis-
tered SCF and IL-11 to mice for 6 days beginning 6 weeks
after marrow transplantation. Treated mice doubled the
amount of LTR activity, relative to saline-treated controls,
detectable in marrow and spleen 8 weeks after cytokine
treatment and 3 months after the original transplant
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Figure 2
Kinetics of marrow recovery post-transplant. (a) Marrow cellularity and
cells measurable in short-term colony assays (CFC) regenerate briskly
to normal levels (shaded zone) within a time frame dependent on the
amount of reconstituting activity injected. During this period, LTRCs
also increase in number but much more slowly. (b) In the model
depicted, LTRCs (S) undergo either symmetrical (shaded oval)
divisions that yield two daughter LTRCs or asymmetrical divisions that
yield only a single daughter with LTR potential and a sibling destined
to  differentiate (D). Boxes surround the clones derived from three
consecutive divisions of a single LTRC. The pedigree on the left,
generated during logarithmic marrow recovery, includes a symmetrical
division and yields a clone containing two LTRCs and six differentiating
cells. After marrow cellularity is restored to normal, LTRC divisions
become predominantly asymmetrical to maintain but not increase the
numbers of stem cells in the clones they generate. Our results suggest
that stem cells can switch reversibly from one mode to the other
depending mainly on signals read from their environment.
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Figure 1
Relationship between fold-expansion of LTR activity and number of
marrow cells or CUs transplanted. Individual data points are taken from
the tables. Regression lines were computed by least squares analysis
of the data logarithms and yielded coefficients of correlation virtually
identical to the Spearman rank correlations (shown).
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(Table 2). The result reinforces the view that self-renewal
of LTRCs is susceptible to external control, and further
suggests that complete stem cell regeneration to normal
levels after transplant might be achievable with more
extended cytokine treatment.
Our results support stem cell dilution [18] and refute
exhaustion as an interpretation of earlier results obtained
with indirect measurements. During serial transplantation
in irradiated hosts, LTRCs increase in number repeatedly
without evidence of exhaustion, and the balance between
maintenance and increase is reversible and susceptible to
external control. To account for the failure of stem cells
to regenerate to normal levels after transplant, we
propose, in agreement with [14], that self-renewal of stem
cells is regulated and limited by the cytokine environ-
ment. Early post-irradiation, growth is favoured with
enhanced self-renewal. Since increase in stem cell
numbers must be limited by continuous loss of progeny
to differentiation [19], they regenerate more slowly than
their differentiating progeny (Figure 2). As progenitor
and maturing cells reach normal levels, feedback mecha-
nisms downregulate the stimulus not only for their own
proliferation, but also for stem cell regeneration. Self-
renewal of LTRCs then falls, prematurely, to a level that
only maintains their numbers even though they remain
far short of normal.
Clinical transplant recipients display a life-long deficit in
marrow reserve evidenced by blunted leukocytic
responses to infection and labile platelet counts. The
ability of stem cells to respond to administered cytokines
suggests a potential opportunity for improvement of trans-
planted marrow function in human recipients.
Supplementary material
Figures illustrating the experimental designs, and a table showing the
relationship between LTRC regeneration and number of marrow cells
injected are published with this paper on the internet. 
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Table 2
Enhancement of LTRC expansion in vivo by administration of
SCF and IL-11.
Treatment Reconstituted CU/mouse
BM Spleen BM + spleen
Saline 3.03 ± 1.07 0 3.03 ± 1.07
IL-11 4.66 ± 2.09 0.475 ± 0.278 5.14 ± 2.05
SCF* 8.58 ± 6.47 0.340 ± 0.198 8.92 ± 6.58
IL-11 + SCF 5.94 ± 1.50 1.96 ± 0.690 7.90 ± 1.53†
See Supplementary material for diagrammatic representation of the
protocol used. Each figure represents the mean of four independent
experiments, each experiment involving one treated mouse, two
competitive assay recipients of treated BM and one competitive assay
recipient of treated spleen cells. *rhuIL-11 and rratPEG-SCF, each
100 µg kg–1, were injected s.c. on each of 6 successive days.
†Significantly different from vehicle alone at 5% confidence level. 
